Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Podcasts
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 76, Issue 9
Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Clinical and epidemiological research
Extended report
Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis
Online download statistics by month:
Online download statistics by month: May 2017 to March 2024
Abstract
Full
Pdf
May 2017
5
1143
579
Jun 2017
72
315
259
Jul 2017
370
370
354
Aug 2017
833
840
444
Sep 2017
530
534
322
Oct 2017
336
337
297
Nov 2017
321
322
276
Dec 2017
424
426
288
Jan 2018
453
454
267
Feb 2018
350
328
211
Mar 2018
464
455
68
Apr 2018
307
307
84
May 2018
365
367
82
Jun 2018
246
248
106
Jul 2018
217
217
60
Aug 2018
276
276
66
Sep 2018
224
224
64
Oct 2018
230
231
64
Nov 2018
234
234
45
Dec 2018
188
188
31
Jan 2019
212
210
34
Feb 2019
168
165
43
Mar 2019
149
135
47
Apr 2019
110
106
40
May 2019
114
113
27
Jun 2019
125
123
37
Jul 2019
79
76
36
Aug 2019
98
92
44
Sep 2019
76
69
25
Oct 2019
96
90
44
Nov 2019
81
72
26
Dec 2019
93
86
48
Jan 2020
83
81
28
Feb 2020
90
88
31
Mar 2020
85
86
33
Apr 2020
78
78
49
May 2020
71
71
29
Jun 2020
90
89
44
Jul 2020
78
77
41
Aug 2020
92
92
28
Sep 2020
93
93
40
Oct 2020
137
136
42
Nov 2020
127
126
40
Dec 2020
92
91
40
Jan 2021
82
82
37
Feb 2021
103
101
32
Mar 2021
98
98
31
Apr 2021
81
81
29
May 2021
95
94
26
Jun 2021
94
93
32
Jul 2021
74
69
30
Aug 2021
77
76
21
Sep 2021
119
113
24
Oct 2021
121
118
44
Nov 2021
95
92
43
Dec 2021
102
102
39
Jan 2022
117
119
36
Feb 2022
134
134
36
Mar 2022
175
177
42
Apr 2022
159
162
38
May 2022
179
190
52
Jun 2022
115
115
17
Jul 2022
92
90
15
Aug 2022
121
119
28
Sep 2022
172
171
38
Oct 2022
113
115
19
Nov 2022
104
103
32
Dec 2022
73
69
19
Jan 2023
103
99
27
Feb 2023
104
100
18
Mar 2023
123
116
21
Apr 2023
90
86
31
May 2023
109
104
26
Jun 2023
87
85
24
Jul 2023
111
103
24
Aug 2023
89
89
32
Sep 2023
105
104
22
Oct 2023
220
210
31
Nov 2023
261
242
43
Dec 2023
174
154
28
Jan 2024
107
104
24
Feb 2024
107
104
25
Mar 2024
125
114
85
Total
13572
14758
6084
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?